In summary, our results indicated that LAGE3 was upregulated in HCC, and higher LAGE3 expression was correlated with shorter OS, worse prognosis, and was associated with infiltration of numerous immune cells in HCC patients. This evidence concerns the gene LAGE3 and hepatocellular carcinoma.